Aspirin for primary prevention of cardiovascular disease in diabetes
Journal of Diabetes Investigation Jan 17, 2019
Xing Y, et al. - Since cardiovascular disease (CVD) is a major cause of morbidity and mortality in people with diabetes, researchers have investigated the role of aspirin in the primary prevention of CVD in people with diabetes. Aspirin is commonly used in the treatment and prevention of CVD and the efficacy of aspirin in the secondary prevention of CVD in people with or without diabetes is well established. Although diabetes increases the cardiovascular risk that aspirin could have a greater benefit, it remains unclear whether there is a clear net benefit of aspirin in the primary prevention of CVD in people with diabetes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries